| mirTrans: a resource of transcriptional regulation on microRNAs for human cell lines X Hua, R Tang, X Xu, Z Wang, Q Xu, L Chen, E Wingender, J Li, C Zhang, ... Nucleic acids research 46 (D1), D168-D174, 2018 | 23 | 2018 |
| NBBC: a non-B DNA burden explorer in cancer Q Xu, J Kowalski Nucleic Acids Research 51 (W1), W357-W364, 2023 | 7 | 2023 |
| myCMIE: My cancer molecular information exchange Q Xu, J Kowalski Iscience 26 (8), 2023 | 4 | 2023 |
| A case series exploration of multi-regional expression heterogeneity in triple-negative breast cancer patients Q Xu, J Kaur, D Wylie, K Mittal, H Li, R Kolachina, M Aleskandarany, ... International Journal of Molecular Sciences 23 (21), 13322, 2022 | 3 | 2022 |
| MoCoLo: a testing framework for motif co-localization Q Xu, IMA Del Mundo, M Zewail-Foote, BT Luke, KM Vasquez, J Kowalski Briefings in Bioinformatics 25 (2), bbae019, 2024 | 2 | 2024 |
| Frequently Together, Among Model Systems Molecular Alterations: Cancer Maintenance Markers with Translational Study Design M Ylagan, Q Xu, J Kowalski bioRxiv, 2024.01. 26.577415, 2024 | 2 | 2024 |
| Differential gain of chromosomal regions 20q or 13q with loss of 8p and 18q differentiates disease-free survival in colorectal cancer. E Chao, Q Xu, A Capasso, SG Eckhardt, J Kowalski Journal of Clinical Oncology 39 (3_suppl), 126-126, 2021 | 2 | 2021 |
| primirTSS: an R package for identifying cell-specific microRNA transcription start sites P Li, Q Xu, X Hua, Z Xie, J Li, J Wang Bioinformatics 36 (11), 3605-3606, 2020 | 2 | 2020 |
| Non-B DNA-informed mutation burden as a marker of treatment response and outcome in cancer Q Xu, J Kowalski British Journal of Cancer, 1-8, 2024 | 1 | 2024 |
| TTSBBC: triplex target site biomarkers and barcodes in cancer M Ylagan, Q Xu, J Kowalski Nucleic Acids Research, gkae312, 2024 | 1 | 2024 |
| PACMIDS: Patient-Centered, AI-Enabled, Molecular-Informed Data Fabric for Clinical Treatment Decision Support J Kowalski, Q Xu, M Ylagan, M Hurtado-Castillo, T Aldawoodi, ... AI in Precision Oncology 1 (2), 127-144, 2024 | 1 | 2024 |
| KRAS mutation methylation clonality in early-stage pancreatic cancer. J Kowalski, Q Xu, HP Chao, H Gandhi, KL Aung, WH Matsui Journal of Clinical Oncology 40 (4_suppl), 614-614, 2022 | 1 | 2022 |
| Shared DNA-based copy number with divided methylation changes differentiate and clinically associate early stage pancreatic cancer tumors. E Chao, KL Aung, Q Xu, WH Matsui, J Kowalski Journal of Clinical Oncology 39 (3_suppl), 434-434, 2021 | 1 | 2021 |
| Cell cycle traverse rate predicts long-term outcomes in a multi-institutional cohort of patients with triple-negative breast cancer S Bhattarai, M Rupji, H Chao, Q Xu, G Saini, P Rida, MA Aleskandarany, ... BJC reports 2 (1), 87, 2024 | | 2024 |
| NBBC: Quantifying the Prevalence of Non-B DNA Motifs as a Marker of Non-B Burden in Cancer Q Xu, J Kowalski bioRxiv, 2024.01. 04.574106, 2024 | | 2024 |
| Motif-informed analysis of phenotype heterogeneity in cancer Q Xu | | 2023 |
